“…Our previous work using the PI3K inhibitor, Ly294002, suggested that LMP2A utilizes PI3K to increase IL-10 production (Incrocci, McCormack, and Swanson-Mungerson, 2013). However, due to the identification that Ly294002 can also affect NF-kB activation (Avni, Glucksam, and Zor, 2012), we wanted to confirm our previous findings through the use of the more PI3K-specific inhibitor Wortmannin (Avni, Glucksam, and Zor, 2012). Therefore, LMP2A-expressing and non-expressing B cell lines were incubated in the absence or presence of Wortmannin for 24 hours and IL-10 levels were once again analyzed by ELISA.…”